Search
for
Sort by
Research 571–600 of 1000+
- Lysophospholipid Mediators in Health and Disease
- High-throughput T cell receptor sequencing identifies clonally expanded CD8+ T cell populations in alopecia areata
- Pathomechanisms of immune-mediated alopecia
- Dutasteride
- Solubilizing steroidal drugs by β-cyclodextrin derivatives
- Female pattern alopecia: current perspectives
- Exploiting Unique Features of Microneedles to Modulate Immunity
- Quality of life in children and adolescents with alopecia areata—A systematic review
- Anticancer agents against malaria: time to revisit?
- Evaluation of Stigma Toward Individuals With Alopecia
- ACE2 and TMPRSS2 Potential Involvement in Genetic Susceptibility to SARS-COV-2 in Cancer Patients
- Race and Alopecia Areata amongst US Women
- Profile of tofacitinib citrate and its potential in the treatment of moderate-to-severe chronic plaque psoriasis
- Ritlecitinib and brepocitinib demonstrate significant improvement in scalp alopecia areata biomarkers
- Prevalence, comorbidities, and treatment patterns of Japanese patients with alopecia areata: A descriptive study using Japan medical data center claims database
- How drug repurposing can advance drug discovery: challenges and opportunities
- Dutasteride reduces alcohol’s sedative effects in men in a human laboratory setting and reduces drinking in the natural environment
- HSD3B1 Genotypes Conferring Adrenal-Restrictive and Adrenal-Permissive Phenotypes in Prostate Cancer and Beyond
- The Association of Alopecia Areata-Related Emotional Symptoms with Work Productivity and Daily Activity Among Patients with Alopecia Areata
- Rare and common genetic determinants of metabolic individuality and their effects on human health
- Resident human dermal γδT-cells operate as stress-sentinels: Lessons from the hair follicle
- Risk Factors and Characterization of Vitiligo and Alopecia Areata in Patients With Chronic Graft-vs-Host Disease
- Photobiomodulation for the management of hair loss
- Outcomes in Clinically Relevant Patient Subgroups From the EMBRACA Study: Talazoparib vs Physician’s Choice Standard-of-Care Chemotherapy
- Ejaculatory dysfunction in the treatment of lower urinary tract symptoms
- Alopecia in patients with COVID-19: A systematic review and meta-analysis
- Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream
- Analysis of dermatology-related search engine trends during the COVID-19 pandemic: Implications for patient demand for outpatient services and telehealth
- Impaired Hair Growth and Wound Healing in Mice Lacking Thyroid Hormone Receptors
- Bendamustine in Indolent Non-Hodgkin's Lymphoma: A Practice Guide for Patient Management